scispace - formally typeset
A

Ahmed Nabawy

Researcher at University of Massachusetts Amherst

Publications -  9
Citations -  487

Ahmed Nabawy is an academic researcher from University of Massachusetts Amherst. The author has contributed to research in topics: Biofilm & Medicine. The author has an hindex of 3, co-authored 5 publications receiving 92 citations.

Papers
More filters
Journal ArticleDOI

Nanomaterial-based therapeutics for antibiotic-resistant bacterial infections

TL;DR: The mechanisms by which nanomaterials can be used to target antibiotic-resistant bacterial infections are discussed, design elements and properties of nanomMaterials that can be engineered to enhance potency are highlighted, and recent progress and remaining challenges for clinical implementation are explored.
Journal ArticleDOI

Nanotherapeutics using all-natural materials. Effective treatment of wound biofilm infections using crosslinked nanoemulsions.

TL;DR: The engineered nanoemulsions demonstrate broad-spectrum antimicrobial activity towards drug-resistant bacterial biofilms and significantly expedite wound healing in an in vivo murine wound biofilm model.
Journal ArticleDOI

Biodegradable Poly(lactic acid) Stabilized Nanoemulsions for the Treatment of Multidrug-Resistant Bacterial Biofilms.

TL;DR: The X-NE platform combines the degradability of functionalized poly(lactic acid) polymers with the antimicrobial activity of carvacrol (from oregano oil).
Journal ArticleDOI

Dual antimicrobial-loaded biodegradable nanoemulsions for synergistic treatment of wound biofilms.

TL;DR: In this article , a biodegradable polymeric nanoemulsions that encapsulate two hydrophobic antimicrobial agents (eugenol and triclosan) (TE-BNEs) are used to combat chronic wound infections.
Journal ArticleDOI

Activity of Biodegradable Polymeric Nanosponges against Dual-Species Bacterial Biofilms

TL;DR: The described engineered nanosponges demonstrated broad-spectrum antimicrobial activity through prevention of dual-species biofilm formation as well as eradication of preformed biofilms and showed no toxicity against mammalian cells, highlighting the therapeutic potential of this platform.